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Abstract 
Objective: To describe the cross-sectional and longitudinal associations between quantitative 
measures of infrapatellar fat pad (IPFP) signal intensity alteration and knee structural abnormalities in 
patients with symptomatic knee OA. 
Methods: 261 participants (mean age 63.0 ± 7.2 years) with symptomatic knee OA were selected 
from a randomized controlled trial with a follow up of 2 years. IPFP signal intensity alterations at 
baseline were quantitatively measured on T2-weighted fat-saturated MRI using MATLAB. These 
quantitative measures included the standard deviation [sDev (IPFP)] of whole IPFP signal intensity, 
the upper quartile value [UQ (H)] of high signal intensity, the ratio of volume of high signal intensity 
alteration to volume of whole IPFP [Percentage (H)] and Clustering factor (H) representing the 
clustering effect of high signal intensity. Cartilage volume and defects, and BMLs were assessed 
using validated measures  
Results: Higher baseline sDev (IPFP), UQ (H) and Clustering factor (H) were associated with greater 
loss of tibial cartilage volume and larger increases in tibiofemoral cartilage defects over 2 years. 
Patients with high and medium tertiles of Clustering factor (H) had greater loss of cartilage volume 
per annum compared with those with low tertile (4.9% and 4.6% vs 3.3% p.a.). Baseline Percentage 
(H) and Clustering factor (H) were positively and significantly associated with increases in 
tibiofemoral BMLs over 2 years. Cross-sectional associations between IPFP measures and knee 
structures were similar but more consistent. 
Conclusion: Quantitative measures of increased signal intensity in the IPFP were associated with 
knee structural abnormalities in tibiofemoral compartment, suggesting that these measurements could 
be used as an additional entry criteria in order to enrich for ‘faster progressors’ in studies of knee OA. 
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Significance and innovations: 
1. Using novel quantitative measurements to assess the variation of IPFP signal intensity 
alterations as well as the extent, quantity and clustering effect of IPFP high signal intensity 
alterations; 
2. These measurements were associated with radiographic osteoarthritis and MRI-assessed knee 
structural abnormalities, and predicted disease progression in tibiofemoral compartment over 
2 years, suggesting they are clinically relevant. 
 
Introduction 
Osteoarthritis (OA) is a common cause of chronic disability in older adults and has been considered as 
a multifactorial condition with risk factors including genetics, aging, female sex, injury and obesity 
(1, 2). Obesity is a primary preventable risk factor which has effects partly through increasing loading 
in the knee joint (3). Obese adipose tissue also has endocrine function that can produce pro-
inflammatory cytokines and adipokines affecting the process of joint degradation (4, 5). Similar to 
systemic adipose tissue, local adipose tissue such as infrapatellar fat pat (IPFP) has the ability of 
secreting pro- and anti-inflammatory cytokines and various adipokines, all of which may play roles in 
maintenance of cartilage and bone homeostasis in the knee joint (6-9). 
 
IPFP is structurally similar to subcutaneous adipose tissue (10) with an abundance of adipocytes, 
immune cells, vessels and nerve fibres (11). Our previous studies reported that larger IPFP size had a 
potentially protective effect on knee symptoms and structural changes (12, 13). Despite its capabilities 
of reducing the impact loading and absorbing forces generated through the knee joint, recent evidence 
suggests that abnormal IPFP appears to play an important role in the initiation and progression of 
knee OA (14) (11). IPFP can be an important local source of age-related inflammation and a central 
contributor to the degradation of neighbouring tissues within the knee (15).  
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Inflammation within IPFP can be assessed using non-contrast enhanced magnetic resonance imaging 
(MRI) (16). High signal intensity alteration of IPFP has been regarded as a surrogate of peripatellar 
synovitis in epidemiological studies (17, 18). We used semi-quantitative measurements to assess 
signal intensity alterations in IPFP and reported that they were significantly associated with knee 
symptoms and structural abnormalities in older adults (19). There are currently few studies that have 
used quantitative measurements to evaluate IPFP signal intensity alterations and to describe their 
relationship with knee osteoarthritic abnormalities (20). We recently established a method to 
quantitatively assess IPFP signal intensity alterations and reported that this method was reproducible, 
and associated with knee structural changes (21). Therefore, our current study aims to describe the 
cross-sectional and longitudinal associations between quantitative measures of IPFP signal intensity 
alterations and knee structural abnormalities in patients with symptomatic knee OA. 
 
Methods 
Participants 
This study was conducted as part of the Vitamin D Effect on Osteoarthritis (VIDEO) study, a 
multicentre randomized, double-blind and placebo-controlled clinical trial for evaluating the effects of 
vitamin D supplementation on knee pain and structural changes in knee OA patients with low 25-
hydroxy vitamin D [25(OH)D] (22). Participants aged between 50 to 79 years with symptomatic knee 
OA for at least 6 months assessed according to American College of Rheumatology (ACR) criteria for 
clinical knee OA (23), visual analogue scale (VAS) scores of more than 20 mm and serum 25 (OH)D 
levels between 12.5 nmol/L and 60 nmol/L were included. Exclusion criteria included grade 3 
radiographic OA according to the Altman’s atlas (24), severe knee pain on standing (more than 80 
mm on a 100 mm VAS), contraindication to MRI, other forms of arthritis such as rheumatoid or 
psoriatic arthritis, severe renal impairment, and others (25). Outcomes were measured at baseline and 
24-months follow-up. The VIDEO study was approved by the Tasmania Health and Human Medical 
Research Ethics Committee (reference number H1040). Written informed consent was obtained from 
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all participants. Our current study consisted of a sample of 261 participants who had sagittal T2-
weighted MRI scans in Tasmania. The sample of 152 participants who had coronal T2-weighted MRI 
scans in Melbourne was not included in this study. Treatment and placebo groups were combined as a 
cohort. 
 
Anthropometrics 
Height was measured to the nearest 0.1 cm (with shoes, socks, and headgear removed) using a 
stadiometer. Weight was measured to the nearest 0.1 kg (with shoes, socks, and bulky clothing 
removed) using a single pair of electronic scales (Model 707; Seca Delta, Hamburg, Germany) that 
were calibrated using a known weight at the beginning of each clinic. Body mass index (BMI) 
[weight (kg)/height2 (m2)] was calculated. 
 
Knee radiographic assessment 
A standing anteroposterior view of the symptomatic knee with 15 degrees of flexion was performed 
for each participant at baseline, and joint space narrowing (JSN) and osteophytes were individually 
assessed on a scale of 0 to 3 (0=normal and 3=most severe) according to the Osteoarthritis Research 
Society International (OARSI) atlas developed by Altman et al (24). JSNs were assessed at medial 
tibiofemoral, lateral tibiofemoral, medial patellofemoral and lateral patellofemoral compartments, 
while osteophytes were assessed at medial tibial, medial femoral, lateral tibial, lateral femoral, medial 
patellar and lateral patellar sites. We summed the osteophyte and JSN scores as total knee 
radiographic OA (ROA) score (range, 0-30), as previously described (26).  
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MRI protocol 
MRI scans of the study knee were obtained according to a standardized protocol using a 1.5 T whole-
body MRI unit with a commercial transmit-receive extremity coil. Fat-suppressed (FS) T2-weighted 
fast spin echo (FSE) sequences were used as described previously (22). The following sequences were 
used: sagittal FS T2-weighted 3D FSE sequence, flip angle 90º, repetition time 3,067 ms, echo time 
112 ms, FOV 16 cm, 15 slices, 228 × 256-pixel matrix slice thickness of 2 mm with no gap. 
 
Measurements of high signal intensity in IPFP 
High signal intensity in IPFP was assessed (by WH) on sagittal planes of FSS T2-weighted images 
using MATLAB as described previously (Figure 1) (21). The segmentation of IPFP was performed at 
ten intermediate slices in whole IPFP in order to avoiding the interference from other tissues (i.e. 
synovium, ligaments and subcutaneous fat) and effusion which were hard to distinguish in the 
beginning and ending slices. This measurement is a semi-automated procedure. An initial lasso was 
automatically created by a set of points selected manually near the outer contour of IPFP and then 
contracted inward to approximate the real boundary of IPFP automatically. High signal intensity 
alterations were obtained by newly developed algorithm. Data were output automatically. We 
previously reported (21): among these measurements, Clustering factor (H) and sDev (IPFP) were 
consistently and significantly associated with all joint structural measurements; Percentage (H) and 
Volume (H) were consistently and significantly associated with knee cartilage defects and ROA but 
not with BMLs, while Median (H) and UQ (H) were only significantly associated with tibiofemoral 
cartilage defects; Mean (IPFP) was not significantly associated with any knee structural 
measurements. 
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All these measures can be classified as four categories: signal intensity of whole IPFP, high signal 
intensity of IPFP, volume of high signal intensity and clustering effect of high signal intensity. Based 
on the concurrent validity and the clinical construct validity we reported, we selected one measure 
from each category into the current study: sDev (IPFP), UQ (H), Percentage (H) and Clustering factor 
(H).  Of them, sDev (IPFP), being introduced to represent signal intensity variation of IPFP, is the 
standard deviation of whole IPFP signal intensity; UQ (H), representing the value of high signal 
intensity, is the upper quartile value of high signal intensity; Percentage (H), being calculated as the 
ratio of volume of high signal intensity region to whole IPFP volume, represents the adjusted quantity 
of high signal intensity; and Clustering factor (H) is calculated as: 
Clustering factor (H) = ∑ ܸ݋݈௜/ ∑ ܸ݋ ௝݈
୬୨ୀଵ୫୧ୀଵ
m/n  
 where, 
m = ቄn ∗ 10%    n > 101                 n ≤ 10 
n is the number of high intensity regions. Vol୨ is the volume of seed group  P୨. ∑ Vol୨୬୨ୀଵ  is the total 
volume of high intensity regions.  ∑ Vol୧୫୧ୀଵ  is the volume of the top m largest high intensity regions. 
Clustering factor (H) reflects the actual clustering effects, the bigger Factor(ୌ) , the greater 
clustering effects. Intraobserver and interobsever reliabilities of these quantitative measurements 
ranged from 0.92 to 0.96 (intraclass correlation coefficient, ICC) and from 0.90 to 0.94, respectively. 
 
Measures for knee structural abnormalities 
Cartilage volume was assessed using the previously described image processing techniques (27). The 
volumes of individual cartilage plates (medial tibial, lateral tibial and patellar) were isolated by 
manually drawing disarticulation contours around the cartilage boundaries on a section-by-section 
basis then resampled by means of bilinear and cubic interpolation for final 3D rendering using OsiriX 
Lite imaging software (32-bit version 5·9, Pixmeo SARL, Geneva, Switzerland). Total tibial cartilage 
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volume was summed, and change in cartilage volume per annum was defined as (follow-up – 
baseline)/interval. The coefficient of variation (CV) was 2·1% for medial tibia and 2·2% for lateral 
tibia (28).  
 
Cartilage defects were evaluated using a modified Outerbridge classification (29) at medial tibial, 
lateral tibial, medial femoral, lateral femoral, femoral trochlear, and patellar  sites: grade 0, normal 
cartilage; grade 1, focal blistering and intracrtilaginous hyperintensity with an normal contour; grade 
2, irregularities on the surface and loss of thickness of less than 50%; grade 3, deep ulceration with 
loss of thickness of more than 50% without exposure of subchondral bone; grade 4, full thickness 
chondral wear with exposure of subchondral bone. A total score was calculated as the total of 
subregional scores with a maximum score of 24. Presence of tibiofemoral cartilage defects was 
defined as any tibial or femoral cartilage defects of >= grade 2, and an increase in cartilage defects 
was defined as the value from (follow-up cartilage defects – baseline cartilage defects) of >= 1. Intra-
observer reliabilities (expressed as ICCs) ranged from 0.89 to 0.94 for different compartments. Inter-
observer reliabilities were assessed in 50 MR images and yielded correlation coefficients of 0.85 to 
0.93 for different compartments (30).  
 
Subchondral bone marrow lesions (BMLs) were defined as discrete areas of increased signal adjacent 
to the subchondral bone. They were measured semi-quantitatively using the modified Whole-Organ 
Magnetic Resonance Imaging Score (WORMS) method (31). BMLs were scored from 0 to 3 based on 
the extent of subregional involvement (0 = none; 1 = < 25% of the subregion; 2 = 25-50%; 3 = 
>50%). The ICCs were 0.93-0.98 for this scoring system (32). Any presence of tibiofemoral BMLs 
was defined as a BML score of >= grade 1, and an increase in BMLs was defined as the value from 
(follow-up BMLs – baseline BMLs) of >= 1.  
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Data analysis 
Baseline characteristics were summarised using descriptive statistics. Univariable and multivariable 
linear regression analyses were used to examine the associations between baseline IPFP signal 
intensity alteration measures (independent variables) and baseline ROA score, and baseline and 
change in tibial cartilage volume (dependent variables). The associations between baseline IPFP 
signal intensity alteration measures (independent variables) and the presence of or increase in 
tibiofemoral cartilage defects and BMLs (dependent variables) over 2 years were assessed using 
logistic regression analyses. The associations were adjusted for age, sex and BMI in cross-sectional 
analyses, and adjusted for age, sex, BMI and vitamin D treatment allocation in longitudinal analyses. 
Interactions between the measurements of IPFP high signal intensity alterations and sex or BMI on 
knee structural abnormalities were assessed by testing the statistical significance of the coefficient of 
a (sex or BMI × measures of IPFP high signal intensity alteration).  
 
Multivariable linear/logistic regression was used to analyse the difference in change in tibial cartilage 
volume or an increase in tibiofemoral cartilage defects/BMLs over 2 years among tertiles of 
Clustering factor (H), in Figure 2, which visualised the association between knee structural changes 
and Clustering factor (H). 
 
A p-value < 0.05 (2-tailed) or a 95% confidence interval (CI) not including the null (for linear 
regression) or 1 (for logistic regression) point was considered as statistical significance. All statistical 
analyses were performed on SPSS version 20.0 for Windows (SPSS Inc., Chicago, IL). 
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Results 
Characteristics of the study population are presented in Table 1. A total of 261 participants (49.4% 
females) between 50 and 79 years of age (mean, 63.0 years) took part in the present study. There were 
no significant differences in demographic factors (age, sex, and BMI) between these participants and 
those who were excluded from this study due to no sagittal knee MRI scans available (n = 152) (data 
not shown). The mean baseline total score of radiographic OA was 6.9, and the mean tibial cartilage 
volume was 3.7 ml. Tibiofemoral cartilage defects and any tibiofemoral BMLs were present in 53.3% 
and 65.3% of participants, respectively. Using quantitative measurements, the values of sDev (IPFP), 
UQ (H), Percentage (H) and Clustering factor (H) were presented in Table 1. 
 
Cross-sectional associations  
All baseline IPFP signal intensity alteration measures were significantly and positively associated 
with total radiographic OA score and presence of tibiofemoral cartilage defects and BMLs, but not 
significantly with presence of patellar cartilage defects and BMLs, in both univariable and 
multivariable analyses (Table S1-S3). Baseline Percentage (H) and Clustering factor (H) were 
significantly and negatively associated with tibial cartilage volume, while sDev (IPFP) and UQ (H) 
were significantly and negatively associated with patellar cartilage volume, in multivariable analyses 
(Table S4). 
 
Longitudinal associations 
Cartilage volume loss 
Higher baseline sDev (IPFP), UQ (H) and Clustering factor (H) were significantly associated with 
greater tibial cartilage loss, but not associated with patellar cartilage loss, over 2 years before and after 
adjustment for covariates (Table 2). Patients with low tertile of Clustering factor (H) had 3.3% loss of 
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cartilage volume per annum (p.a.), while those with medium tertile had 4.6% loss of cartilage volume 
p.a., and with high tertile had 4.9% loss of cartilage volume p.a. (Figure 2a). The results were similar 
when medial and lateral tibial cartilage volumes were analysed individually (data not shown). 
 
Increase in cartilage defects 
Higher baseline sDev (IPFP), UQ (H) and Clustering factor (H) were significantly associated with 
higher risks of an increase in tibiofemoral cartilage defects over 2 years in both univariable and 
multivariable analyses, while all baseline IPFP signal intensity alteration measures were not 
associated with increase in patellar cartilage defects (Table 3). There was a significant and positive 
association between tertiles of Clustering factor (H) and an increase in tibiofemoral cartilage defects 
(Figure 2b). 
 
Increase in BMLs 
Higher baseline Percentage (H) and Clustering factor (H) were significantly associated with higher 
risks of an increase in tibiofemoral BMLs over 2 years in both univariable and multivariable analyses. 
In contrast, there were no significant associations between all baseline IPFP signal intensity alteration 
measures and an increase in patellar BMLs in both analyses (Table 4). Tertiles of baseline Clustering 
factor (H) were positively associated with an increase in tibiofemoral BMLs over 2 years (Figure 2c). 
 
The results were similar when tertiles of other baseline IPFP signal intensity measures were used as 
independent variables (data not shown). Baseline IPFP signal intensity alteration was positively 
associated with baseline effusion-synovitis but not with changes in effusion-synovitis (data not 
shown). There were no significant interactions between the measurements of IPFP signal intensity 
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alterations and sex or BMI on knee structural abnormalities (data not shown); therefore, men and 
women, and those who were normal weight, overweight or obese were combined for analyses. 
 
Discussion 
This is the first study to describe the longitudinal associations between quantitative measures of IPFP 
signal intensity alteration and knee structural abnormalities in patients with symptomatic knee OA. 
We found that, quantitative measurements of IPFP high signal intensity alteration were significantly 
associated with increased ROA, tibiofemoral cartilage defects and BMLs, and reduced cartilage 
volume at baseline. Furthermore, most of higher baseline IPFP high signal intensity alteration 
measures were significantly associated with greater tibial cartilage volume loss and increases in 
tibiofemoral cartilage defects and BMLs over 2 years. In contrast, these quantitative measurements 
were not significantly associated with knee structural abnormalities at patellar site. 
 
IPFP is the biggest adipose tissue structure within the knee. Abundant with adipocytes, immune cells 
and vessels (11), IPFP is an important source of inflammatory cytokines and adipokines (5, 7-9), 
which can be a key contributor to knee OA. A pathological study illustrated that there were vascular 
neoformations, fibrosis, and chronic inflammation in IPFP obtained from end-stage OA patients (33). 
T2-weighted FSE MRI can be used to assess IPFP signal intensity alterations (16), and these high 
signal intensity alterations may represent inflammation and vascular neoformations in IPFP. Several 
clinical and epidemiological studies used high signal intensity alteration of IPFP as a surrogate for 
peripatellar synovitis (17, 18); however, the measurement was semi-quantitative. Our study uses a 
quantitative assessment of IPFP signal intensity alteration, which is more objective and includes more 
details of IPFP signal intensity changes. In addition to the rare report of associations between IPFP 
signal intensity alterations and knee structural changes in patients with knee OA, the results of the 
current study suggested that IPFP signal intensity quantitative measurements could be considered as 
outcome measures in future knee OA research. 
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Routine radiography is considered as the gold diagnostic standard of OA in clinical practice due to the 
ability of revealing joint space loss and osteophytes at the joint margin, and this method provides an 
indirect measurement of cartilage loss (34). The OARSI atlas developed by Altman et al (24) is 
frequently used to assess features of radiographic OA (35). Our current study found that all measures 
of signal intensity alteration were positively associated with radiographic knee OA in patients with 
symptomatic knee OA. Our findings are consistent with two recent publications using semi-
quantitative assessments of IPFP signal intensity alteration. Atukorala et al reported that Hoffa-
synovitis (assessed as high signal intensity alterations in IPFP) strongly predicted the incidence of 
radiographic knee OA (36). We recently reported signal intensity alteration score was significantly 
associated with radiographic knee OA in population-based older adults (19). We were unable to 
evaluate the temporal relationship between IPFP signal intensity alteration and ROA, as  X-ray 
assessment was only performed at baseline as an exclusion criteria in the original clinical trial. 
 
Cartilage loss is generally considered as a major feature of OA progression. Inflammatory and 
metabolic factors, such as interleukin 6 (IL-6), tumor necrosis factor α (TNFα) and leptin, have been 
involved in cartilage breakdown and eventually cartilage loss(37, 38). Klein-Wieringa et al reported 
that IPFP in patients with knee OA could secrete higher levels of inflammatory mediators (IL-6, 
adipsin, adiponectin, and visfatin) that contributed to the pathogenesis of cartilage loss (6). Other 
studies also showed that IPFP in knee OA could release pro-inflammatory factors and adipokines that 
could induce cartilage degradation (7, 39). Our previous observational study illustrated that semi-
quantitative measure of IPFP signal intensity alteration was significantly and positively associated 
with tibiofemoral cartilage loss in older adults (19). Consistent with these reports, we found that 
baseline sDev (IPFP), UQ (H) and Clustering factor (H) were associated with tibiofemoral cartilage 
volume loss and cartilage defects (focal cartilage loss) in patients with symptomatic knee OA over 2 
years in the current study. Both studies did not find significant associations between IPFP signal 
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intensity alterations and patellar cartilage volume loss. In this study, nearly half of the participants 
were with grade 4 patellar cartilage defects, and only 15% of participants had an increase in patellar 
cartilage defects. Moreover, the change in patellar cartilage volume was only one third of change in 
tibiofemoral cartilage volume. The patellofemoral compartment had more severe disease and less 
changes than the tibiofemoral compartment, and this may be the reason that we did not find 
significant associations with changes in patellar compartment. This may also explain why we only 
found significantly cross-sectional associations with cartilage defects and BMLs in tibiofemoral 
compartment. Moreover, we found that, cross-sectionally, some measures (Percentage (H), Clustering 
factor (H)) were related tibial cartilage volume, while others (sDev (IPFP), UQ (H)) were 
significantly related to patellar cartilage volume. The reasons underlying these discrepancies are 
unclear but the cross-sectional findings were not the focus of our current study. 
 
Subchondral BMLs have been considered as a hallmark of OA and been related with cartilage damage 
and pain in the initiation and progression of OA (40, 41). These subchondral pathological lesions may 
be influenced by inflammatory mediators (42) and may have a cross-talk with IPFP pathological 
changes through inflammatory pathways. Our previous study reported that high signal intensity 
alteration score in IPFP was significantly and positively associated with BMLs in older adults, 
suggesting there may be a link between IPFP and subchondral bone changes in the process of knee 
OA (19). Consistently, our current study reported that baseline Percentage (H) and Clustering factor 
(H) were associated with tibiofemoral BMLs in patients with symptomatic knee OA, while there were 
no significant associations between these quantitative measures and patellar BMLs. 
 
Our current study used a novel and a semi-automatic method to assess signal intensity alterations in 
IPFP with the output of quantitative measures. Using this new method, our results were consistent 
with previous semi-quantitative methodology, suggesting the pathology of IPFP signal intensity 
alteration may play an important role in the progression of knee OA. Furthermore, these quantitative 
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measures are more objective and the results showed that Clustering factor (H), sDev (IPFP) and UQ 
(H), but not Percentage (H), had stronger associations with knee structure changes. These measures 
may reflect different magnitudes of pathological changes of IPFP, and this is why they were 
associated with different MRI-assessed knee structural changes of knee OA. Further pathological 
studies are needed to identify these differences. Overall, Clustering factor (H) was more consistently 
associated with all MRI-assessed knee structural changes, suggesting it may be a more useful 
biomarker for future research. Although this quantitative methodology focused on high rather than 
low signal intensity alterations in IPFP, it included more details of IPFP signal intensity alteration 
than previous semi-quantitative methodology and had more advantages over this semi-quantitative 
one.  It will enrich the MRI-based whole joint assessment of knee OA, and could be included in 
selection of participants for future clinical trials in knee OA as by excluding those in the low tertile of 
increased signal intensity in the IPFP thus enriching for those with faster progression of knee OA. 
This measure appears to provide an additional selection method, independent of age, gender, 
radiological grade and other structural changes.  
 
The main strength of this study is that we used a novel quantitative measurement to assess the signal 
intensity alterations in IPFP. Additionally, this study included blind readings and the standardized 
methods used for data acquisition with high intra- and inter- reader reliabilities. This study has several 
potential limitations. First, as this study is conducted as a post-hoc analysis within a subsample of a 
RCT it may not generalizable to general population of knee OA and needs further confirmations in the 
further studies. Second, MRI coronal planes were used at Melbourne so the quantitative measures in 
these participants were unable to be performed; however, there were no significant differences in 
demographic factors between participants included and excluded from this study. Third, histological 
examinations were not able to perform in our study so the pathological changes of IPFP signal 
intensity alterations are unknown. Fourth, more severe structural abnormalities in patellofemoral 
compartment at baseline would result in “ceiling effects” for the changes, which could be the reason 
why we did not detect significantly longitudinal associations in patellofemoral compartment. Future 
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studies are required to examine these in patients without advanced disease in this compartment. Last, 
measurement error may influence results. However, all measures were highly reproducible suggesting 
this is unlikely. 
 
In conclusion, the quantitative measures of IPFP signal intensity alteration were significantly and 
positively associated with knee structural abnormalities in tibiofemoral compartment over 2 years in 
patients with symptomatic knee OA, suggesting that the pathology of IPFP may play an important 
role in knee OA progression. Additionally, these quantitative measurements of IPFP signal intensity 
alterations could be used as an additional entry criteria in order to enrich for ‘faster progressors’ in 
studies of in knee OA. 
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Table 1. Baseline characteristics of participants 
Characteristic Values*(n = 261) 
Age (years) 63.0 (7.2) 
Female sex (%) 49.4 
BMI (kg/m2) 29.7 (4.9) 
ROA (grade, 0 - 30) 6.9 (5.0) 
Tibial cartilage volume (ml)  3.7 (1.1) 
Tibiofemoral cartilage defects present 
(%) 
53.3 
Any tibiofemoral BMLs present (%) 65.3 
sDev (IPFP)  8.4 (2.9) 
UQ (H)  4.2 (1.4) 
Percentage (H)  6.9 (1.3) 
Clustering factor (H)  6.3 (0.9) 
*Mean (SD) or percentage of patients. BMI: body mass index; IPFP: infrapatellar fat pad; ROA: 
radiographic osteoarthritis; BMLs: bone marrow lesions; sDev (IPFP): standard deviation of IPFP 
signal intensity values; UQ(H): upper quartile value of high signal intensity region; Percentage (H): 
ratio of volume of high signal intensity region/whole IPFP volume; Clustering factor(H): clustering 
factor of high signal intensity. Presence of tibiofemoral cartilage defects was defined as any tibial 
or femoral cartilage defects of >= grade 2. Any presence of tibiofemoral BMLs was defined as a 
BML score of >= grade 1. 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
Table 2. Longitudinal associations between baseline IPFP signal intensity alteration and changes in 
cartilage volume  
 
Univariable Multivariable* 
 
β (95% CI) β (95% CI) 
Change in tibial cartilage volume 
  
sDev (IPFP) -0.34 (-0.61, -0.08) -0.37 (-0.65, -0.09) 
UQ (H) -0.90 (-1.51, -0.29) -0.93 (-1.56, -0.31) 
Percentage (H) -0.13 (-0.54, 0.28) -0.15 (-0.56, 0.26) 
Clustering factor (H) -1.01 (-1.66, -0.35) -1.41 (-2.25, -0.57) 
Change in patellar cartilage volume 
  
sDev (IPFP) -0.10 (-0.45, 0.25) -0.05 (-0.41, 0.32) 
UQ (H) -0.21 (-0.92, 0.51) -0.11 (-0.85, 0.62) 
Percentage (H) -0.02 (-0.58, 0.54) -0.04 (-0.61, 0.53) 
Clustering factor (H) -0.59 (-1.73, 0.56) -0.47 (-1.63, 0.70) 
Dependent variable: cartilage volume; Independent variable: IPFP signal intensity alteration.  
*Adjusted for age, gender, BMI, tibial bone area and treatment allocation. 
IPFP: infrapatellar fat pad; sDev (IPFP): standard deviation of IPFP signal intensity values; UQ(H): 
upper quartile value of high signal intensity region; Percentage (H): ratio of volume of high signal 
intensity region/whole IPFP volume; Clustering factor(H): clustering factor of high signal intensity. 
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Table 3. Longitudinal associations between baseline IPFP signal intensity alteration and increase in 
cartilage defects 
 
Univariable Multivariable* 
 
RR (95% CI) RR (95% CI) 
Increase in tibiofemoral cartilage defects 
  
sDev (IPFP) 1.33 (1.16, 1.53) 1.37 (1.18, 1.58) 
UQ (H) 2.00 (1.46, 2.74) 2.10 (1.51, 2.92) 
Percentage (H) 0.90 (0.76, 1.08) 0.89 (0.74, 1.07) 
Clustering factor (H) 2.15 (1.44, 3.22) 2.19 (1.46, 3.30) 
Increase in patellar cartilage defects 
  
sDev (IPFP) 0.01 (-0.01, 0.03) 0.01 (-0.01, 0.03) 
UQ (H) 0.03 (-0.01, 0.06) 0.03 (-0.01, 0.06) 
Percentage (H) -0.02 (-0.04, 0.01) -0.03 (-0.05, 0.01) 
Clustering factor (H) 0.03 (-0.02, 0.09) 0.03 (-0.02, 0.08) 
Dependent variable: cartilage defects; Independent variable: IPFP signal intensity alteration.  
*Adjusted for age, gender, BMI and treatment allocation. 
IPFP: infrapatellar fat pad; sDev (IPFP): standard deviation of IPFP signal intensity values; UQ(H): 
upper quartile value of high signal intensity region; Percentage (H): ratio of volume of high signal 
intensity region/whole IPFP volume; Clustering factor(H): clustering factor of high signal intensity. 
An increase in cartilage defects was defined as the value from (follow-up cartilage defects – baseline 
cartilage defects) of >= 1. 
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Table 4. Longitudinal associations between baseline IPFP signal intensity alteration and increase in 
BMLs 
 
Univariable Multivariable* 
 
RR (95% CI) RR (95% CI) 
Increase in tibiofemoral BMLs 
  
sDev (IPFP) 1.09 (0.96, 1.23) 1.09 (0.96, 1.24) 
UQ (H) 1.10 (0.83, 1.45) 1.08 (0.81, 1.44) 
Percentage (H) 1.28 (1.06, 1.55) 1.28 (1.05, 1.55) 
Clustering factor (H) 1.47 (1.00, 2.17) 1.52 (1.02, 2.26) 
Increase in patellar BMLs 
  
sDev (IPFP) 0.00 (-0.02, 0.02) 0.00 (-0.02, 0.02) 
UQ (H) -0.01 (-0.04, 0.02) -0.01 (-0.05, 0.03) 
Percentage (H) 0.02 (-0.01, 0.04) 0.02 (-0.01, 0.05) 
Clustering factor (H) 0.00 (-0.06, 0.06) 0.00 (-0.06, 0.06) 
Dependent variable: BMLs; Independent variable: IPFP signal intensity alteration.  
*Adjusted for age, gender BMI and treatment allocation. 
BMLs: bone marrow lesions; IPFP: infrapatellar fat pad; sDev (IPFP): standard deviation of IPFP 
signal intensity values; UQ(H): upper quartile value of high signal intensity region; Percentage (H): 
ratio of volume of high signal intensity region/whole IPFP volume; Clustering factor(H): clustering 
factor of high signal intensity. 
An increase in BMLs was defined as the value from (follow-up BMLs – baseline BMLs) of >= 1. 
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Figure legends 
Figure 1. Measurements of signal intensity alteration in IPFP using MATLAB.  
Semi-automatic segmentations of IPFP were performed first. Then, high signal intensity regions, 
showing as the red areas, were obtained by newly developed algorithm 
Figure 1A has the lowest Percentage (H) and Clustering factor (H), and Figure 1B has the highest 
sDev (IPFP) and UQ (H). Although Figure 1B and Figure 1C have similar Percentage (H) and 
Clustering factor (H), they have different sDev (IPFP) and UQ (H). Figure 1D has the biggest 
Percentage (H), but its sDev (IPFP) and UQ (H) are lower than Figure 1B. 
 
Figure 2. Longitudinal associations between Clustering factors of the high signal intensity alterations 
in IPFP and knee structural changes over 2 years.  
(A) Change of tibial cartilage volume per annum (%); (B) Increase in tibiofemoral cartilage defects 
(%); (C) Increase in tibiofemoral BMLs (%). 
 *p values were those after adjustment for baseline age, gender, BMI, and treatment allocation.   
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